It’s not too much to say that if successful, the Pridgen antiviral trial for Fibromyalgia would be a paradigm changer.
Turning a difficult to treat ‘central nervous system disorder’ into a treatable (hopefully) herpesvirus infection disorder would be an amazing shift and it’s not surprising that excitement about the results are high. Just as we thought they were going to be released, however, the lines went dead.
Now Dr. Pridgen gives us a brief overview of the results, tells us when they will be released and discusses plans for the Chronic Fatigue Syndrome to follow in a blog on Simmaron Rising
Like the blogs? Use the Subscribe button on the right sidebar to support Health Rising painlessly with a $5 or $10 month recurring donation.